Literature DB >> 15802093

Autoimmune hepatitis.

Heike Bantel1, Christian P Strassburg, Michael P Manns.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15802093     DOI： 10.1007/s11894-005-0042-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  14 in total

Review 1.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self.

Authors:  M P Manns; M J Bahr
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

3.  The new immunology--the end of immunosuppressive drug therapy?

Authors:  R S Schwartz
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

4.  Autoimmune hepatitis in childhood: a 20-year experience.

Authors:  G V Gregorio; B Portmann; F Reid; P T Donaldson; D G Doherty; M McCartney; A P Mowat; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 5.  The emerging role of CTLA-4 as an immune attenuator.

Authors:  C B Thompson; J P Allison
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

Review 6.  Liver transplantation in autoimmune liver disease--selection of patients.

Authors:  H L Tillmann; E Jäckel; M P Manns
Journal:  Hepatogastroenterology       Date:  1999 Nov-Dec

7.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

8.  LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

Authors:  M P Manns; K J Griffin; K F Sullivan; E F Johnson
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.

Authors:  A W Lohse; H P Dienes; K H Meyer zum Büschenfelde
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.

Authors:  M Manns; G Gerken; A Kyriatsoulis; M Staritz; K H Meyer zum Büschenfelde
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321
View more
  1 in total

1.  Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.

Authors:  Susanne Tan; Nils Vollmar; Sven Benson; Jan-Peter Sowa; Lars P Bechmann; Guido Gerken; Dagmar Fuhrer; Ali Canbay
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.